Drug Profile
Lidocaine/prilocaine topical - AstraZeneca
Alternative Names: Emla Patch; EmlapatchLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class Acetanilides; Anilides; Class Ib antiarrhythmics; Erectile dysfunction therapies; Local anaesthetics; Non-opioid analgesics; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaesthesia
Most Recent Events
- 06 Jan 2023 Discontinued - Phase-I for Anaesthesia (In volunteers) in Germany (Topical)
- 28 Nov 2020 No recent reports of development identified for phase-I development in Anaesthesia(In volunteers) in Germany (Topical, Patch)
- 05 Feb 2019 Chemical structure information added